Abstract
The multidrug resistance protein 4 (MRP4) is an efflux transporter involved in the transport of endogenous substrates and xenobiotics. We measured MRP4 mRNA and protein expression in human livers and found a 38- and 45-fold variability, respectively. We sequenced 2 kb of the 5′-flanking region, all exons and intron/exon boundaries of the MRP4 gene in 95 patients and identified 74 genetic variants including 10 non-synonymous variations, seven of them being located in highly conserved regions. None of the detected polymorphisms was significantly associated with changes in the MRP4 mRNA or protein expression. Immunofluorescence microscopy indicated that none of the non-synonymous variations affected the cellular localization of MRP4. However, in cholestatic patients the MRP4 mRNA and protein expression both were significantly upregulated compared to non-cholestatic livers (protein: 299±138 vs 100±60a.u., P<0.001). Taken together, human hepatic MRP4 expression is highly variable. Genetic variations were not sufficient to explain this variability. In contrast, cholestasis is one major determinant of human hepatic MRP4 expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Ho RH, Kim RB . Transporters and drug therapy: implications for drug disposition and disease. Clin Pharmacol Ther 2005; 78: 260–277.
Ito K, Suzuki H, Horie T, Sugiyama Y . Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport. Pharm Res 2005; 22: 1559–1577.
Fromm MF . Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 2004; 25: 423–429.
Keppler D . Uptake and efflux transporters for conjugates in human hepatocytes. Methods Enzymol 2005; 400: 531–542.
Cascorbi I . Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 2006; 112: 457–473.
Borst P, de Wolf C, van de Wetering K . Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch 2007; 453: 661–673.
Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D . Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 2003; 38: 374–384.
van Aubel RA, Smeets PH, Peters JG, Bindels RJ, Russel FG . The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol 2002; 13: 595–603.
Wielinga PR, van der Heijden I, Reid G, Beijnen JH, Wijnholds J, Borst P . Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 2003; 278: 17664–17671.
Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden I, Schuetz JD et al. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J 2003; 371: 361–367.
Rius M, Hummel-Eisenbeiss J, Hofmann AF, Keppler D . Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. Am J Physiol Gastrointest Liver Physiol 2006; 290: G640–649.
Reid G, Wielinga P, Zelcer N, van der Heijden I, Kuil A, de Haas M et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal anti-inflammatory drugs. Proc Natl Acad Sci USA 2003; 100: 9244–9249.
Zamek-Gliszczynski MJ, Nezasa KI, Tian X, Bridges AS, Lee K, Belinsky MG et al. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3−/− and Abcc4−/− mice. J Pharmacol Exp Ther 2006; 319: 1485–1491.
Sampath J, Adachi M, Hatse S, Naesens L, Balzarini J, Flatley RM et al. Role of MRP4 and MRP5 in biology and chemotherapy. AAPS PharmSci 2002; 4: E14.
Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G et al. Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem 2004; 279: 22250–22257.
Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C et al. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 2005; 42: 420–430.
Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C et al. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 2001; 276: 39411–39418.
Denk GU, Soroka CJ, Takeyama Y, Chen WS, Schuetz JD, Boyer JL . Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol 2004; 40: 585–591.
Mennone A, Soroka CJ, Cai SY, Harry K, Adachi M, Hagey L et al. Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology 2006; 43: 1013–1021.
Keitel V, Burdelski M, Warskulat U, Kuhlkamp T, Keppler D, Haussinger D et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 2005; 41: 1160–1172.
Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV et al. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med 1999; 5: 1048–1051.
Borst P, Balzarini J, Ono N, Reid G, de Vries H, Wielinga P et al. The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy. Antiviral Res 2004; 62: 1–7.
Adachi M, Sampath J, Lan LB, Sun D, Hargrove P, Flatley R et al. Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J Biol Chem 2002; 277: 38998–39004.
Wielinga PR, Reid G, Challa EE, van der Heijden I, van Deemter L, de Haas M et al. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol 2002; 62: 1321–1331.
Chen ZS, Lee K, Kruh GD . Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J Biol Chem 2001; 276: 33747–33754.
Anderson PL, Lamba J, Aquilante CL, Schuetz E, Fletcher CV . Pharmacogenetic Characteristics of Indinavir, Zidovudine, and Lamivudine Therapy in HIV-Infected Adults: A Pilot Study. J Acquir Immune Defic Syndr 2006; 42: 441–449.
Stephens M, Smith NJ, Donnelly P . A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978–989.
Marschall HU, Wagner M, Zollner G, Fickert P, Diczfalusy U, Gumhold J et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005; 129: 476–485.
Stedman C, Liddle C, Coulter S, Sonoda J, Alvarez JG, Evans RM et al. Benefit of farnesoid X receptor inhibition in obstructive cholestasis. Proc Natl Acad Sci USA 2006; 103: 11323–11328.
Wagner M, Fickert P, Zollner G, Fuchsbichler A, Silbert D, Tsybrovskyy O et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 2003; 125: 825–838.
Boyer JL, Trauner M, Mennone A, Soroka CJ, Cai S-Y, Moustafa T et al. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OST{alpha}-OSTbeta in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1124–G1130.
Maher JM, Cheng X, Tanaka Y, Scheffer GL, Klaassen CD . Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice. Biochem Pharmacol 2006; 72: 512–522.
Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 2001; 11: 399–415.
Hitzl M, Klein K, Zanger UM, Fritz P, Nussler AK, Neuhaus P et al. Influence of omeprazole on multidrug resistance protein 3 expression in human liver. J Pharmacol Exp Ther 2003; 304: 524–530.
den Dunnen JT, Antonarakis SE . Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15: 7–12.
König J, Cui Y, Nies AT, Keppler D . A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol 2000; 278: G156–164.
Jedlitschky G, Tirschmann K, Lubenow LE, Nieuwenhuis HK, Akkerman JW, Greinacher A et al. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood 2004; 104: 3603–3610.
Pschyrembel W . Pschyrembel: Klinisches Wörterbuch/Pschyrembel Clinical Dictionary. 259th German edition, de Gruyter: Berlin, New York, 2002.
Saito S, Iida A, Sekine A, Miura Y, Ogawa C, Kawauchi S et al. Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR). J Hum Genet 2002; 47: 147–171.
Acknowledgements
Supported by the DFG (Bonn, FR 1298/2-4), the grant 0313080D (HepatoSys, to UMZ) from the German Federal Ministry of Education and Science, the HW & J Hector Foundation (Mannheim) and by the Robert Bosch Foundation (Stuttgart), Germany.
Author information
Authors and Affiliations
Corresponding author
Additional information
Duality of Interest
There are no dualities of interest.
Rights and permissions
About this article
Cite this article
Gradhand, U., Lang, T., Schaeffeler, E. et al. Variability in human hepatic MRP4 expression: influence of cholestasis and genotype. Pharmacogenomics J 8, 42–52 (2008). https://doi.org/10.1038/sj.tpj.6500451
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500451
Keywords
This article is cited by
-
Regulation of ABC transporters by sex steroids may explain differences in drug resistance between sexes
Journal of Physiology and Biochemistry (2023)
-
ABCC4 functional SNP in the 3′ splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia
Cancer Chemotherapy and Pharmacology (2017)
-
Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia
The Pharmacogenomics Journal (2015)
-
Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles
Journal of Gastroenterology (2015)
-
Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium
Clinical Pharmacology & Therapeutics (2013)